Latest News in the pharma Industry

Research & Development

Amgen Discusses Details of the BLA for Talimogene Laherparepvec for Patients with Metastatic Melanoma

Amgen Discusses Details of the BLA for Talimogene Laherparepvec for Patients with Metastatic Melanoma

30 Apr 2015

Read more 
GSK Candidate Vaccine for the Prevention of Shingles Demonstrates Overall Efficacy of 97.2%

GSK Candidate Vaccine for the Prevention of Shingles Demonstrates Overall Efficacy of 97.2%

29 Apr 2015

Read more 
IDT Opens Molecular Biology R&D Facility in Redwood City

IDT Opens Molecular Biology R&D Facility in Redwood City

28 Apr 2015

Read more 
Synthon Announces Successful Outcomes from the Open-label Extension of the Phase III GATE Study of Synthon’s Glatiramer Acetate

Synthon Announces Successful Outcomes from the Open-label Extension of the Phase III GATE Study of Synthon’s Glatiramer Acetate

28 Apr 2015

Read more 
Merck Announces Publication of Pivotal Data from Phase III Clinical Studies of Zerbaxa

Merck Announces Publication of Pivotal Data from Phase III Clinical Studies of Zerbaxa

28 Apr 2015

Read more 
AMSBIO has Launched a New and Exclusive Biotinylated Protein Collection

AMSBIO has Launched a New and Exclusive Biotinylated Protein Collection

28 Apr 2015

Read more 
MSD Announces Results from its Pivotal Phase III C-EDGE Programme and C-SURFER Trial

MSD Announces Results from its Pivotal Phase III C-EDGE Programme and C-SURFER Trial

27 Apr 2015

Read more 
Janssen Announces Phase III OPTIMIST Data

Janssen Announces Phase III OPTIMIST Data

27 Apr 2015

Read more 
Mitotech Announces Phase II Data Showing Positive Effect of SkQ1 in Patients with Dry Eye Syndrome

Mitotech Announces Phase II Data Showing Positive Effect of SkQ1 in Patients with Dry Eye Syndrome

23 Apr 2015

Read more 
Study Finds that Microinjection Platform Enables Assessment of Multiple Cancer Drugs Directly in Tumours

Study Finds that Microinjection Platform Enables Assessment of Multiple Cancer Drugs Directly in Tumours

23 Apr 2015

Read more 
Lilly Releases Early-Stage Pipeline Data at AACR Annual Meeting 2015

Lilly Releases Early-Stage Pipeline Data at AACR Annual Meeting 2015

21 Apr 2015

Read more 
Merck Submits Supplemental Biologics License Application FDA for Keytruda (Pembrolizumab) in Advanced NSCLC

Merck Submits Supplemental Biologics License Application FDA for Keytruda (Pembrolizumab) in Advanced NSCLC

21 Apr 2015

Read more